Zobrazeno 1 - 10
of 345
pro vyhledávání: '"Disbrow GL"'
Autor:
Hofmeyer KA; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Ventura CL; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Armstrong KL; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Houchens CR; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Patel S; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Disbrow GL; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA., Johnson RA; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC, USA.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 19; Vol. 79 (1), pp. 115-121.
Autor:
Johnson RA; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA., White RC; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA.; Booz Allen Hamilton, McLean, VA, USA., Disbrow GL; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2129930. Date of Electronic Publication: 2022 Oct 27.
Autor:
Buchman TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; Emory University, Atlanta, GA, United States. Electronic address: Tim.Buchman@hhs.gov., Simpson SQ; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; University of Kansas, Kansas City, KS, United States., Sciarretta KL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States., Finne KP; Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States., Sowers N; Acumen, LLC, Burlingame, CA, United States., Collier M; Acumen, LLC, Burlingame, CA, United States., Chavan S; Acumen, LLC, Burlingame, CA, United States., Do R; Acumen, LLC, Burlingame, CA, United States; Division of Cardiovascular Medicine, Department of Medicine, University of California, Irvine, CA, United States., Lin C; Acumen, LLC, Burlingame, CA, United States., Oke I; Acumen, LLC, Burlingame, CA, United States., Rhodes KE; Acumen, LLC, Burlingame, CA, United States., Santhosh A; Acumen, LLC, Burlingame, CA, United States., Sandhu AT; Acumen, LLC, Burlingame, CA, United States; Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, United States., Chu S; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD, United States., Patel SA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States., Disbrow GL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States., Bright RA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; Rockefeller Foundation, New York, NY, United States., MaCurdy TE; Acumen, LLC, Burlingame, CA, United States; Department of Economics, Stanford University, Stanford, CA, United States., Kelman JA; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD, United States.
Publikováno v:
Vaccine [Vaccine] 2021 Dec 20; Vol. 39 (52), pp. 7569-7577. Date of Electronic Publication: 2021 Nov 24.
Autor:
Frank CE; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC.; Emory Critical Care Center, Emory University, Atlanta, GA., Buchman TG; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC.; Emory Critical Care Center, Emory University, Atlanta, GA., Simpson SQ; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC.; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas, Kansas City, KS., Sciarretta KL; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC., Plopper GE; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC.; Booz Allen Hamilton, McLean, VA., Finne KP; United States Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Washington, DC., Sowers N; Acumen, LLC, Burlingame, CA., Collier M; Acumen, LLC, Burlingame, CA., Chavan S; Acumen, LLC, Burlingame, CA., Lin C; Acumen, LLC, Burlingame, CA., Oke I; Acumen, LLC, Burlingame, CA., Rhodes KE; Acumen, LLC, Burlingame, CA., Santhosh A; Acumen, LLC, Burlingame, CA., Chu S; United States Department of Health and Human Services, Center for Medicare and Medicaid Services, Baltimore, MD., MaCurdy TE; Acumen, LLC, Burlingame, CA., Patel SA; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC., Disbrow GL; United States Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Washington, DC., Kelman JA; United States Department of Health and Human Services, Center for Medicare and Medicaid Services, Baltimore, MD.
Publikováno v:
Critical care medicine [Crit Care Med] 2021 Dec 01; Vol. 49 (12), pp. 2058-2069.
Autor:
Buchman TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.; Emory Critical Care Center, Emory University, Atlanta, GA., Simpson SQ; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas, Kansas City, KS., Sciarretta KL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Finne KP; Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Sowers N; Acumen, LLC, Burlingame, CA., Collier M; Acumen, LLC, Burlingame, CA., Chavan S; Acumen, LLC, Burlingame, CA., Oke I; Acumen, LLC, Burlingame, CA., Pennini ME; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Santhosh A; Acumen, LLC, Burlingame, CA., Wax M; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Woodbury R; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Chu S; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD., Merkeley TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Disbrow GL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Bright RA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., MaCurdy TE; Acumen, LLC, Burlingame, CA.; Department of Economics, Stanford University, Stanford, CA.; Hoover Institution, Stanford University, Stanford, CA.; Stanford Institute for Economic Policy Research, Stanford University, Stanford, CA., Kelman JA; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD.
Publikováno v:
Critical care medicine [Crit Care Med] 2020 Mar; Vol. 48 (3), pp. 276-288.
Autor:
Buchman TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.; Emory Critical Care Center, Emory University, Atlanta, GA., Simpson SQ; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas, Kansas City, KS., Sciarretta KL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Finne KP; Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Sowers N; Acumen, LLC, Burlingame, CA., Collier M; Acumen, LLC, Burlingame, CA., Chavan S; Acumen, LLC, Burlingame, CA., Oke I; Acumen, LLC, Burlingame, CA., Pennini ME; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Santhosh A; Acumen, LLC, Burlingame, CA., Wax M; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Woodbury R; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Chu S; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD., Merkeley TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Disbrow GL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Bright RA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., MaCurdy TE; Acumen, LLC, Burlingame, CA.; Department of Economics, Stanford University, Stanford, CA.; Hoover Institution, Stanford University, Stanford, CA.; Stanford Institute for Economic Policy Research, Stanford University, Stanford, CA., Kelman JA; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD.
Publikováno v:
Critical care medicine [Crit Care Med] 2020 Mar; Vol. 48 (3), pp. 289-301.
Autor:
Buchman TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.; Emory Critical Care Center, Emory University, Atlanta, GA., Simpson SQ; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC.; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kansas, Kansas City, KS., Sciarretta KL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Finne KP; Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC., Sowers N; Acumen, LLC, Burlingame, CA., Collier M; Acumen, LLC, Burlingame, CA., Chavan S; Acumen, LLC, Burlingame, CA., Oke I; Acumen, LLC, Burlingame, CA., Pennini ME; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Santhosh A; Acumen, LLC, Burlingame, CA., Wax M; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Woodbury R; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Chu S; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD., Merkeley TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Disbrow GL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., Bright RA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, Washington, DC., MaCurdy TE; Acumen, LLC, Burlingame, CA.; Department of Economics, Stanford University, Stanford, CA.; Hoover Institution, Stanford University, Stanford, CA.; Stanford Institute for Economic Policy Research, Stanford University, Stanford, CA., Kelman JA; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD.
Publikováno v:
Critical care medicine [Crit Care Med] 2020 Mar; Vol. 48 (3), pp. 302-318.
Autor:
Wolfe DN; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States. Electronic address: daniel.wolfe2@hhs.gov., Zarrabian AG; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States., Disbrow GL; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States., Espeland EM; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States.
Publikováno v:
Vaccine [Vaccine] 2019 Nov 15; Vol. 37 (48), pp. 7178-7182. Date of Electronic Publication: 2017 Dec 02.
Autor:
Espeland EM; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America., Tsai CW; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America., Larsen J; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America., Disbrow GL; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America.
Publikováno v:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Apr 05; Vol. 12 (4), pp. e0006275. Date of Electronic Publication: 2018 Apr 05 (Print Publication: 2018).
Autor:
Larsen JC; Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington DC., Disbrow GL; Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services, Washington DC.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2017 May 15; Vol. 64 (10), pp. 1430-1434. Date of Electronic Publication: 2017 Feb 04.